National Planning Corporation’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-25,065
Closed -$462K 647
2017
Q3
$462K Sell
25,065
-560
-2% -$12.3K 0.04% 386
2017
Q2
$644K Sell
25,625
-103
-0.4% -$2.17K 0.05% 344
2017
Q1
$517K Hold
25,728
0.04% 377
2016
Q4
$534K Hold
25,728
0.04% 356
2016
Q3
$597K Sell
25,728
-74
-0.3% -$1.37K 0.05% 328
2016
Q2
$496K Hold
25,802
0.04% 375
2016
Q1
$362K Sell
25,802
-280
-1% -$3.21K 0.03% 435
2015
Q4
$274K Sell
26,082
-773
-3% -$8.42K 0.02% 545
2015
Q3
$305K Sell
26,855
-500
-2% -$5.83K 0.03% 456
2015
Q2
$321K Sell
27,355
-500
-2% -$7.79K 0.03% 458
2015
Q1
$438K Hold
27,855
0.04% 395
2014
Q4
$431K Buy
27,855
+126
+0.5% +$1.83K 0.03% 454
2014
Q3
$401K Buy
27,729
+113
+0.4% +$1.61K 0.03% 468
2014
Q2
$391K Sell
27,616
-293
-1% -$4.45K 0.03% 492
2014
Q1
$486K Buy
27,909
+745
+3% +$12.3K 0.04% 381
2013
Q4
$386K Buy
27,164
+504
+2% +$6.93K 0.03% 448
2013
Q3
$363K Buy
26,660
+976
+4% +$12.1K 0.04% 434
2013
Q2
$264K Buy
+25,684
New +$289K 0.03% 417

Other funds holding PMD

National Planning Corporation's PMD Position: Q4 2017 in Review

National Planning Corporation sold out of Psychemedics Corporation (PMD) in Q4 2017, closing a stake of 25,065 shares — an estimated $462K sold.

National Planning Corporation first reported a position in PMD in Q2 2013 and held it in 18 quarters. The position peaked at $644K in Q2 2017. 46 funds tracked by Wall St. Rank hold PMD as of Q4 2017.

  • National Planning Corporation reported no remaining Psychemedics Corporation position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 25,065 Psychemedics Corporation shares in Q4 2017, an estimated $462K.
  • National Planning Corporation first reported a position in Psychemedics Corporation in Q2 2013 and held it in 18 quarters.
  • National Planning Corporation's Psychemedics Corporation position peaked at $644K in Q2 2017.
  • 46 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.